A phase II trial of lenvatinib in patients with metastatic colorectal cancer after standard chemotherapy
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2612407
下载链接
链接失效反馈官方服务：
资源简介：
Intervention type:DRUG. Intervention1:Lenvatinib, Dose form:CAPSULE, Route of administration:ORAL, intended dose regimen:24mg of lenvatinib is orally taken once daily for 28 days each course.
Primary outcome(s): Disease control rate. Timepoint:Every 4 weeks (4th week, 8th week) until 8 weeks from the starting date of treatment
, and every 8 weeks (16th week, 24th week, and so on ) after 9 weeks from the starting date of treatment.
创建时间：
2016-10-15
